Serono Symposia International Foundation adheres to guidelines of the European Accreditation Council for Continuing Medical Education (EACCME) and all other professional organizations, as applicable, which state that programs awarding continuing education credits must be balanced, independent, objective, and scientifically rigorous. Investigative and other uses for pharmaceutical agents, medical devices, and other products (other than those uses indicated in approved product labeling/package insert for the product) may be presented in the program (which may reflect clinical experience, the professional literature or other clinical sources known to the presenter). We ask all presenters to provide participants with information about relationships with pharmaceutical or medical equipment companies that may have relevance to their lectures. This policy is not intended to exclude faculty who have relationships with such companies; it is only intended to inform participants of any potential conflicts so participants may form their own judgments, based on full disclosure of the facts. Further, all opinions and recommendations presented during the program and all program-related materials neither imply an endorsement, nor a recommendation, on the part of Serono Symposia International Foundation. All presentations solely represent the independent views of the presenters/authors.

The following faculty indicated no significant commercial relationships and/or discussions of investigational or non- EMEA/FDA approved (off-label) uses of drugs:

Pierre Duquette
Roberta Motta
Josée Poirier

The following faculty provided information regarding significant commercial relationships and/or discussions of investigational or non- EMEA/FDA approved (off-label) uses of drugs:

Trudy Campbell: Declared receipt of grants and contracts from Novartis, BioMS, Genentech, Genzyme, Teva Neuroscience, Biogen Idec, EMD Serono, Bayer. Declared receipt of honoraria or consultation fees from Teva Neuroscience, Biogen Idec, EMD Serono, Bayer. Declared to be member of Teva Neuroscience, Bayer, Biogen Idec, EMD Serono, IOMS advisory board, board of directors or other similar group. In addition declared that her presentation will include discussion of off labeled or otherwise non-approved uses of products: “Presentation of use in research using research study findings; statement that the product is used off label”.

Mark Freedman: Declared receipt of honoraria or consultation fees from EMD Serono, Bayer Health Care, Teva, Biogen Idec, Genentech, Sanofi Aventis, Novartis, BioMS. Declared to be member of Sanofi Aventis, Novartis advisory board, board of directors or other similar group. Declared to participate in a Pfizer sponsored speaker’s bureau.

François Grand’Maison: Declared receipt of grants and contracts from Novartis, Aventis, Biogen Idec, Bayer, Teva, Genzyme. Declared to be member of EMD Serono advisory board.

June Halper: Declared to be member of Bayer Healthcare Pharmaceuticals, Novartis, Genentech advisory board, board of directors or other similar group.

Colleen Harris: Declared receipt of honoraria or consultation fees from EMD Serono, Biogen Idec, Bayer Healthcare, Teva Neurosciences, Novartis.

Dawn Langdon: Receipt of grants and contracts from Bayer Schering funding of PHD studenship. Recipt of honoraria or consultation fees from Bayer, Biogen, Serono. Member of a Roche, Bayer advisory board, board of directors or other similar group. Partecipates in Bayer, Biogen, Serono, Teva sponsored speaker's bureau

Liesly Lee: Declared receipt of grants and contracts from BioMS, Teva Neuroscience, EMD Serono, Biogen, Bayer. Declared receipt of honoraria or consultation fees from BioMS, Teva Neuroscience, EMD Serono, Biogen, Bayer. Declared to be member of EMD Serono advisory board, board of directors or other similar group.

Magnhild Sandberg-Wollheim: Declared receipt of honoraria or consultation fees from Serono Nordic, Merck Serono, Aventis, Bayer Health Care (former Schering), Serono Symposia International Foundation, Genentech. Declared to be member of Active Biotech AB board of directors.

Jaume Sastre-Garriga: Declared to partecipate in a Serono and Sanofi-Aventis sponsored speaker's bureau.